Vaccination with metastasis-related tumor associated antigen TPD52 and CpG/ODN induces protective tumor immunity

By Payton Laura   Lewis Jennifer   Byrne Jennifer   Bright Robert  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 6, 2008-06 ,pp. : 799-811

Springer Publishing Company

Access to resources Recommend Favorite

Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9

By Zhang Yuyi   Lin Ang   Zhang Cai   Tian Zhigang   Zhang Jian  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 357-367

Springer Publishing Company

Access to resources Recommend Favorite

Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity

By Alteber Zoya   Azulay Meir   Cafri Gal   Vadai Ezra   Tzehoval Esther   Eisenbach Lea  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 369-380

Springer Publishing Company

Access to resources Recommend Favorite

CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production

By Li Xiaoli  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1607-1618

Springer Publishing Company

Access to resources Recommend Favorite

TRAIL is involved in CpG ODN-mediated anti-apoptotic signals

By Lim Eun-Jung   Park Dae-Weon   Jeong Tae-Whal   Chin Byung-Rho   Bae Yoe-Sik   Baek Suk-Hwan  

Oncology Reports, Vol. 27, Iss. 4, 2012-04 ,pp. : 1213-1218

Spandidos Publications

Access to resources Recommend Favorite